Diagnostic News and Research

RSS

Prexion receives FDA approval for Eclipse 3D Cone Beam Computed Tomography Dental Scanner

Today, Prexion, Inc. announced FDA approval of the The Eclipse 3D Cone Beam Computed Tomography Dental Scanner.

8 May 2013

BIOTRONIK receives FDA approval for ICD/CRT-D series

BIOTRONIK, a leading manufacturer of cardiovascular medical technology, announced that the Food and Drug Administration granted approval for its Ilesto 7 implantable cardioverter-defibrillator/cardiac resynchronization therapy defibrillator series.

8 May 2013

First Edition: May 7, 2013

Today's headlines include reports about two new studies exploring whether the slowdown in the nation's health spending growth rates is, in fact, due more to structural changes in the health ystem than to the economy.

7 May 2013

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

Kinase inhibitors are molecules that block the activity of kinases. Kinases are a specific class of enzymes. They are extremely important in signal transduction processes in the human body meaning that they actually regulate most of the physiological processes that take place in the body.

7 May 2013

Study examines link between families with exceptional longevity and cognitive impairment

A study by Stephanie Cosentino, Ph.D., of Columbia University, New York, and colleagues examines the relationship between families with exceptional longevity and cognitive impairment consistent with Alzheimer disease.

7 May 2013

TBI in older adults presents special diagnostic, management and treatment challenges

Each year more than 1.7 million people in the United States sustain a traumatic brain injury (TBI). The incidence of TBI in older adults poses special diagnostic, management and treatment challenges, say experts in a special collection of papers on TBI in the elderly in NeuroRehabilitation: An Interdisciplinary Journal.

7 May 2013

Minimal dose computed tomography better at detecting new or recurrent lung cancer

Lung cancer is associated with very high mortality, in part because it is hard to detect at early stages, but also because it can recur frequently after surgical removal.

7 May 2013

New protocol for reducing the use of SPECT SPI is found to be diagnostically safe

A new stress test protocol that investigates reducing the use of perfusion imaging in low risk patients undergoing SPECT myocardial perfusion imaging for possible angina symptoms was found to be diagnostically safe, revealed a US retrospective analysis.

6 May 2013

Study estimates ER costs for hematuria patients at more than $237 million a year

A relatively common urinary tract disorder that can usually be managed in an outpatient setting is adding an estimated $238 million a year to the cost of emergency room visits in the U.S., according to two new studies from Henry Ford Hospital in Detroit.

5 May 2013

Research roundup: Surgical care at critical access hospitals; Digging into the cost of emergency medicine; Getting what you want for end-of-life care

During the past 15 years, the number of critical access hospitals – those with fewer than 25 acute care beds that receive higher reimbursements and other considerations from Medicare to help sustain them – has increased substantially, representing a quarter of all U.S. acute care hospitals in 2011.

4 May 2013

New computational method for assessing lung cancer tumors

Moffitt Cancer Center and the University of South Florida have collaborated with researchers in China, the United Kingdom, the Netherlands and Germany to devise a new computational method for assessing lung cancer tumors using CT, PET or MRI diagnostic technologies.

3 May 2013

Study results may help introduce better preoperative treatment for breast cancer

Breast cancers contain many different cell types with different patterns of gene expression, but a new study provides reassurance that this variability should not be a barrier to using gene expression tests to help tailor cancer treatments to individual patients.

3 May 2013

Public-private partnerships can help advance global health goals

"Three people die every minute from tuberculosis -- a treatable and largely preventable disease. Resistant forms continue to thrive, and increased travel makes the global threat very real. We face a public health emergency," Vince Forlenza, chair, CEO, and president of the medical technology firm Becton, Dickinson and Company, writes in the Harvard Business Review Blog Network.

3 May 2013

New evidence-based guideline for using WSI systems for diagnostic work

The College of American Pathologists released today a new evidence-based guideline, "Validating Whole Slide Imaging for Diagnostic Purposes in Pathology." The guideline is the first of its kind and is now available in the CAP's peer-reviewed journal, Archives of Pathology & Laboratory Medicine.

3 May 2013

Shore Medical Center inks affiliation agreement with The Cancer Institute of New Jersey

Shore Medical Center is pleased to announce it has entered into an affiliation agreement with The Cancer Institute of New Jersey - the state's only National Cancer Institute-designated Comprehensive Cancer Center.

3 May 2013

UC San Diego Health System receives national award for providing quality care to cancer patients

UC San Diego Health System is a recipient of the 2012 Outstanding Achievement Award from the American College of Surgeons' Commission on Cancer.

3 May 2013

New approach could democratize viral surveillance, says UCSF scientist

The tick-borne Lone Star virus has been conclusively identified as part of a family of other tick-borne viruses called bunyaviruses, which often cause fever, respiratory problems and bleeding, according to new research led by scientists at UC San Francisco.

3 May 2013

Cancer Genetics introduces proprietary urogenital cancer array for diagnosing kidney cancer

Cancer Genetics, Inc., a leader in oncology-focused personalized medicine, has launched a proprietary urogenital cancer array, UroGenRA, intended for kidney cancer diagnosis and subtyping in its own laboratory.

3 May 2013

Better individual risk prediction for women with breast cancer is getting nearer, says study author

A test that measures the expression levels of 58 genes in oestrogen receptor-positive breast cancers can effectively differentiate between patients who are at higher and lower risk for having their cancer recur elsewhere in the body more than five years after diagnosis, researchers report.

3 May 2013

Prosigna Breast Cancer Prognostic Gene Signature Assay predicts ROR in women with early-stage breast cancer

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced results from two studies that are featured in oral presentations this week at IMPAKT Breast Cancer Conference.

2 May 2013

Diagnostic News and Research

Prexion receives FDA approval for Eclipse 3D Cone Beam Computed Tomography Dental Scanner

BIOTRONIK receives FDA approval for ICD/CRT-D series

First Edition: May 7, 2013

Kinase inhibitors: an interview with Jan Hoflack, CSO of Oncodesign

Study examines link between families with exceptional longevity and cognitive impairment

TBI in older adults presents special diagnostic, management and treatment challenges

Minimal dose computed tomography better at detecting new or recurrent lung cancer

New protocol for reducing the use of SPECT SPI is found to be diagnostically safe

Study estimates ER costs for hematuria patients at more than $237 million a year

Research roundup: Surgical care at critical access hospitals; Digging into the cost of emergency medicine; Getting what you want for end-of-life care

New computational method for assessing lung cancer tumors

Study results may help introduce better preoperative treatment for breast cancer

Public-private partnerships can help advance global health goals

New evidence-based guideline for using WSI systems for diagnostic work

Shore Medical Center inks affiliation agreement with The Cancer Institute of New Jersey

UC San Diego Health System receives national award for providing quality care to cancer patients

New approach could democratize viral surveillance, says UCSF scientist

Cancer Genetics introduces proprietary urogenital cancer array for diagnosing kidney cancer

Better individual risk prediction for women with breast cancer is getting nearer, says study author

Prosigna Breast Cancer Prognostic Gene Signature Assay predicts ROR in women with early-stage breast cancer

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Latest News